Evidence map›Paper›PMID 30126434›Full record

ArticleRadiation oncology (London, England)2018

Evaluation of transperineal ultrasound imaging as a potential solution for target tracking during hypofractionated radiotherapy for prostate cancer.

Bin Han, Mohammad Najafi, David T Cooper, Martin Lachaine, Rie von Eyben, Steven Hancock, Dimitre Hristov

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bin HanDepartment of Radiation Oncology, School of Medicine, Stanford University, 875 Blake Wilbur Drive, Room G203, Palo Alto, CA, 94304, USA.
Mohammad NajafiDepartment of Radiation Oncology, School of Medicine, Stanford University, 875 Blake Wilbur Drive, Room G203, Palo Alto, CA, 94304, USA.
David T CooperElekta Ltd, 2050 Bleury Suite 200, Montréal, QC, H3A 2J5, Canada.
Martin LachaineElekta Ltd, 2050 Bleury Suite 200, Montréal, QC, H3A 2J5, Canada.
Rie von EybenDepartment of Radiation Oncology, School of Medicine, Stanford University, 875 Blake Wilbur Drive, Room G203, Palo Alto, CA, 94304, USA.
Steven HancockDepartment of Radiation Oncology, School of Medicine, Stanford University, 875 Blake Wilbur Drive, Room G203, Palo Alto, CA, 94304, USA.
Dimitre HristovDepartment of Radiation Oncology, School of Medicine, Stanford University, 875 Blake Wilbur Drive, Room G203, Palo Alto, CA, 94304, USA. dimitre.hristov@stanford.edu.
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging hypofractionated prostate radiotherapy regimens require solutions for accurate target tracking during beam delivery. The goal of this study is to evaluate the performance of the Clarity ultrasound monitoring system for prostate motion tracking.

methodsFive prostate patients underwent continuous perineum ultrasound imaging during their daily treatments. Initial absolute 3D positions of fiducials implanted in the prostate were estimated from the KV images. Fiducial positions in MV images acquired during beam delivery were compared with predicted positions based on Clarity 3D tracking. The uncertainty in the comparison results was evaluated in a phantom validation study.

resultsContinuous real-time ultrasound motion tracking was recorded in 5 patients and 167 fractions for overall of 39.7 h. Phantom validation of the proposed procedure demonstrated that predicted and observed fiducial positions agree within 1.1 mm. In patients agreement between predicted and actual fiducial positions varied between 1.3 mm and 3.3 mm. On average ultrasound tracking reduced the maximum localization error in patients by 20% on average. With the motion corrected, the duration prostate beyond 1 mm from its initial treatment position can be reduced from 37 to 22% of the total treatment time.

conclusionReal-time ultrasound tracking reduces uncertainty in prostate position due to intra-fractional motion.

trial registrationIRB Protocol #27372 . Date of registration of trial: 12/17/2013.

Indexed as

Organ MotionRadiation Dose HypofractionationFeasibility StudiesFiducial MarkersHumansMalePhantoms, ImagingProstateProstatic NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy Setup ErrorsUltrasonographyUncertaintyImage-guidanceProstate cancerProstate motionRadiotherapyTrackingUltrasound

Identifiers

PMID30126434
PMCPMC6102861
OpenAlexW2888538538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.